AstraZeneca A/S    

 

Address:

Roskildevej 22

Albertslund, DK-2620

Denmark

Phone:
45 43 66 64 62

Fax:
45 43 66 61 00


Company description

Wholesale: Pharmaceutical products

Log in for comprehensive information about this and hundreds of thousands of other companies.

News and information about AstraZeneca A/S

Exmark: Reasonable Royalty Damages, Apportionment and Expert Opinions
Mondaq Business Briefing; January 29, 2018; 700+ words
...actual practice of using the entire mower for purposes of a reasonable royalty. The Court cited its prior decision in Astrazeneca as addressing "how to account for the relative value of the patentee's invention in comparison to the value of the...
Pieris Pharmaceuticals Posts Financial Results for the Third Quarter Ended September 30, and Releases Corporate Update
Health & Beauty Close-Up; November 14, 2017; 700+ words
...antagonist, by year end. The Company is the Phase 1 clinical trial sponsor for PRS-060, which is partnered with AstraZeneca as part of a respiratory alliance signed in May 2017, with AstraZeneca funding the cost of this study. Dosing of the...
How Will the Life Sciences Strategy Affect Businesses?
States News Service; October 16, 2017; 638 words
...Over three evidence sessions the Committee questions global leaders in pharmaceuticals GlaxoSmithKline (GSK) and AstraZeneca, as well as representatives of Small Medium Enterprises (SMEs) and healthcare regulatory and advice bodies. Parliament...
Bonesupport Holding Names Helena L. Brandt as New Head of HR
Nordic Business Report; October 16, 2017; 394 words
...organisations operating within the field of R & D, has served in global companies such as TetraPak, Sony Ericsson and AstraZeneca, as well as smaller fast growing companies. She has held several, mainly global, HR business partner positions at...
Spain : Phase III AMPLIFY Study Shows Duaklir Significantly Improves Lung Function in Moderate to Very Severe Stable COPD
Mena Report; September 8, 2017; 594 words
...Almirall said: "These results represent a significant milestone for Almirall's respiratory business transferred to AstraZeneca, as they support the previous regarding of Duaklir and will contribute to making this combination treatment available...
19 Questions For: Usman Rasul-Development Chemist, Tilemaster Adhesives
Contract Flooring Journal; July 1, 2017; 700+ words
...Technically this would be Poundland. But the first job in which I was working full-time continuously would have been at AstraZeneca as an associate scientist in pathology, analysing blood samples of volunteers for clinical trials. What was the best...
Orexo Gets USD 2.5 Million Payment from AstraZeneca as OX-CLI Advances into Clinical Trials
Manufacturing Close-Up; June 6, 2017; 403 words
Orexo AB (publ.) reported that the OX-CLI project has advanced into clinical phase I triggering a milestone payment of USD 2.5 million(approx. SEK 23 million) from AstraZeneca.According to a release, OX-CLI is a Leukotriene (LT) C4 Synthase inhibitor program directed to develop a novel treatment of
United States : SalvaRx Group PLC Investment in Rift Biotherapeutics Inc
Mena Report; March 21, 2017; 680 words
...Previously, Dr. Morrison served as Executive Vice President, Global Medicines Development and Chief Medical Officer at AstraZeneca, as Head, Medical Affairs, Safety and Regulatory Affairs for Pfizer's human health business, and also as Vice President...

Search HighBeam Business for more news about AstraZeneca A/S

Industry information

NAICS codes 
North American Industry Classification System (NAICS) codes are used to classify businesses for the purpose of collecting statistical data related to the U.S. economy. NAICS codes have been assigned to international companies to help organize all companies by type of activity.  

Primary: 424210 - Drugs and Druggists' Sundries Merchant Wholesalers


 

SIC codes 
Standard Industrial Classification (SIC) codes classify establishments by their primary type of activity. SIC codes are a U.S. Census Bureau system but can apply to international companies.  

Primary: 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries industry report